GSK Malaria Vaccine Gets Landmark Clearance For Use In Africa
WHO Recommendation Takes Account Of 2015 EMA Scientific Opinion
Mosquirix is set for much wider availability in sub-Saharan Africa thanks to positive results from a pilot program in Ghana, Kenya and Malawi. The next step is deciding how to fund the vaccine’s rollout over the coming years.
You may also be interested in...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended for approval the world's first vaccine for malaria1,2.
Leaked documents show that the European Commission has prepared a new proposal on compulsory licensing of coronavirus products to be tabled at the World Trade Organization’s Ministerial Conference next month.
As discussions continue over the European Commission’s plans to overhaul the EU pharmaceutical legislation, the R&D-based pharma industry body EFPIA says that any new pharma policy framework will need to be stable, fast, effective and globally competitive.